scispace - formally typeset
D

Deniz Gür

Researcher at Hacettepe University

Publications -  117
Citations -  3094

Deniz Gür is an academic researcher from Hacettepe University. The author has contributed to research in topics: Streptococcus pneumoniae & Penicillin. The author has an hindex of 32, co-authored 116 publications receiving 2834 citations. Previous affiliations of Deniz Gür include Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa.

TL;DR: Pseudomonas aeruginosa 455, isolated in Ankara, Turkey, produced a pI 6.2 beta-lactamase determined by plasmid pMLH53 and resisted all beta- lactams except carbapenems.
Journal ArticleDOI

Antimicrobial Susceptibility of Acinetobacter calcoaceticus-Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997-2016).

TL;DR: Important temporal decreases in susceptibility rates among Acb complex isolates were observed for all antimicrobial agents in all regions, and important reductions of susceptibility rates to all antimicrobials obtained from all geographic regions were observed.
Journal ArticleDOI

Survey of the prevalence of βlactamases amongst 1000 Gram-negative bacilli isolated consecutively at the Royal London Hospital

TL;DR: This survey, performed between January and April, 1991, followed a similar study undertaken in early 1982, and chromosomal beta-lactamase derepression (constitutive hyperproduction) was detected in 10/76 isolates of E. cloacae, Enterobacter aerogenes, Citrobacter freundii, Serratia spp.
Journal ArticleDOI

Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin.

TL;DR: The results suggest that the combination of ofloxacin plus rifampin administered for 6 weeks is as effective as doxycycline plus rIFampin given for the same period, regardless of the presence of complications of the disease.
Journal ArticleDOI

Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children

TL;DR: The recognition of risk factors for UTI, caused by ESBL(+) bacteria in children, may aid in the identification of high-risk cases and may enable proper management of these patients.